-
Je něco špatně v tomto záznamu ?
The involvement of selected membrane transport mechanisms in the cellular uptake of (177)Lu-labeled bombesin, somatostatin and gastrin analogues
M. Volková, J. Mandíková, A. Lázníčková, M. Lázníček, P. Bárta, F. Trejtnar,
Jazyk angličtina Země Spojené státy americké
Typ dokumentu časopisecké články, práce podpořená grantem
- MeSH
- biologický transport MeSH
- bombesin chemie metabolismus MeSH
- buněčná membrána metabolismus MeSH
- endocytóza * MeSH
- gastriny chemie metabolismus MeSH
- HeLa buňky MeSH
- izotopové značení MeSH
- lidé MeSH
- lutecium * MeSH
- peptidové hormony chemie metabolismus MeSH
- prasata MeSH
- přenašeče organických aniontů nezávislé na sodíku metabolismus MeSH
- protein 1 přenášející organické anionty metabolismus MeSH
- somatostatin chemie metabolismus MeSH
- zvířata MeSH
- Check Tag
- lidé MeSH
- zvířata MeSH
- Publikační typ
- časopisecké články MeSH
- práce podpořená grantem MeSH
INTRODUCTION: Radiolabeled receptor-targeting peptides are a useful tool for the diagnostic imaging and radiotherapy of some malignancies. However, the retention of radioactivity in the kidney may result in renal radiotoxic injury. This study seeks to evaluate the role of endocytic receptor megalin, renal SLC influx transporters and fluid phase endocytosis (FPE) in the cellular accumulation of radiolabeled peptides. METHODS: In vitro transport cellular studies using megalin ligands (RAP, albumin), fluid phase endocytosis (FPE) inhibitor rottlerin and low temperature were employed to evaluate the transport mechanisms of the peptides. Cells transfected with hOAT1 or hOCT2 were used to analyze the role of these SLC transporters. Somatostatin ((177)Lu-DOTA-[Tyr(3)]octreotate, (177)Lu-DOTA-[1-Nal(3)]octreotide), gastrin ((177)Lu-DOTA-sargastrin) and bombesin ((177)Lu-DOTA-[Pro(1),Tyr(4)]bombesin, (177)Lu-DOTA-[Lys(3)]bombesin, (177)Lu-PCTA-[Lys(3)]bombesin) analogues were involved in the study. RESULTS: RAP, albumin and low temperature decreased the accumulation of all the studied peptides significantly. With one exception, rottlerin caused the concentration dependent inhibition of the cellular accumulation of the radiopeptides. No significant differences in the uptake of the peptides between the control cells and those transfected with hOAT1 or hOCT2 were observed. CONCLUSION: The study showed that active transport mechanisms are decisive for the cellular accumulation in all tested (177)Lu-labeled somatostatin, gastrin and bombesin analogues. Besides receptor-mediated endocytosis by megalin, FPE participates significantly in the uptake. The tested types of renal SLC transporters are not involved in this process.
Citace poskytuje Crossref.org
- 000
- 00000naa a2200000 a 4500
- 001
- bmc15031807
- 003
- CZ-PrNML
- 005
- 20151014103035.0
- 007
- ta
- 008
- 151005s2015 xxu f 000 0|eng||
- 009
- AR
- 024 7_
- $a 10.1016/j.nucmedbio.2014.09.003 $2 doi
- 035 __
- $a (PubMed)25288534
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a xxu
- 100 1_
- $a Volková, M $u Department of Pharmacology and Toxicology, Faculty of Pharmacy in Hradec Králové, Charles University in Prague, Hradec Králové, Czech Republic.
- 245 14
- $a The involvement of selected membrane transport mechanisms in the cellular uptake of (177)Lu-labeled bombesin, somatostatin and gastrin analogues / $c M. Volková, J. Mandíková, A. Lázníčková, M. Lázníček, P. Bárta, F. Trejtnar,
- 520 9_
- $a INTRODUCTION: Radiolabeled receptor-targeting peptides are a useful tool for the diagnostic imaging and radiotherapy of some malignancies. However, the retention of radioactivity in the kidney may result in renal radiotoxic injury. This study seeks to evaluate the role of endocytic receptor megalin, renal SLC influx transporters and fluid phase endocytosis (FPE) in the cellular accumulation of radiolabeled peptides. METHODS: In vitro transport cellular studies using megalin ligands (RAP, albumin), fluid phase endocytosis (FPE) inhibitor rottlerin and low temperature were employed to evaluate the transport mechanisms of the peptides. Cells transfected with hOAT1 or hOCT2 were used to analyze the role of these SLC transporters. Somatostatin ((177)Lu-DOTA-[Tyr(3)]octreotate, (177)Lu-DOTA-[1-Nal(3)]octreotide), gastrin ((177)Lu-DOTA-sargastrin) and bombesin ((177)Lu-DOTA-[Pro(1),Tyr(4)]bombesin, (177)Lu-DOTA-[Lys(3)]bombesin, (177)Lu-PCTA-[Lys(3)]bombesin) analogues were involved in the study. RESULTS: RAP, albumin and low temperature decreased the accumulation of all the studied peptides significantly. With one exception, rottlerin caused the concentration dependent inhibition of the cellular accumulation of the radiopeptides. No significant differences in the uptake of the peptides between the control cells and those transfected with hOAT1 or hOCT2 were observed. CONCLUSION: The study showed that active transport mechanisms are decisive for the cellular accumulation in all tested (177)Lu-labeled somatostatin, gastrin and bombesin analogues. Besides receptor-mediated endocytosis by megalin, FPE participates significantly in the uptake. The tested types of renal SLC transporters are not involved in this process.
- 650 _2
- $a zvířata $7 D000818
- 650 _2
- $a biologický transport $7 D001692
- 650 _2
- $a bombesin $x chemie $x metabolismus $7 D001839
- 650 _2
- $a buněčná membrána $x metabolismus $7 D002462
- 650 12
- $a endocytóza $7 D004705
- 650 _2
- $a gastriny $x chemie $x metabolismus $7 D005755
- 650 _2
- $a HeLa buňky $7 D006367
- 650 _2
- $a lidé $7 D006801
- 650 _2
- $a izotopové značení $7 D007553
- 650 12
- $a lutecium $7 D008187
- 650 _2
- $a protein 1 přenášející organické anionty $x metabolismus $7 D027362
- 650 _2
- $a přenašeče organických aniontů nezávislé na sodíku $x metabolismus $7 D029362
- 650 _2
- $a peptidové hormony $x chemie $x metabolismus $7 D036361
- 650 _2
- $a somatostatin $x chemie $x metabolismus $7 D013004
- 650 _2
- $a prasata $7 D013552
- 655 _2
- $a časopisecké články $7 D016428
- 655 _2
- $a práce podpořená grantem $7 D013485
- 700 1_
- $a Mandíková, J $u Department of Pharmacology and Toxicology, Faculty of Pharmacy in Hradec Králové, Charles University in Prague, Hradec Králové, Czech Republic.
- 700 1_
- $a Lázníčková, A $u Department of Biophysics and Physical Chemistry, Faculty of Pharmacy in Hradec Králové, Charles University in Prague, Hradec Králové, Czech Republic.
- 700 1_
- $a Lázníček, M $u Department of Pharmacology and Toxicology, Faculty of Pharmacy in Hradec Králové, Charles University in Prague, Hradec Králové, Czech Republic.
- 700 1_
- $a Bárta, P $u Department of Pharmacology and Toxicology, Faculty of Pharmacy in Hradec Králové, Charles University in Prague, Hradec Králové, Czech Republic.
- 700 1_
- $a Trejtnar, F $u Department of Pharmacology and Toxicology, Faculty of Pharmacy in Hradec Králové, Charles University in Prague, Hradec Králové, Czech Republic. Electronic address: trejtnarf@faf.cuni.cz.
- 773 0_
- $w MED00008576 $t Nuclear medicine and biology $x 1872-9614 $g Roč. 42, č. 1 (2015), s. 1-7
- 856 41
- $u https://pubmed.ncbi.nlm.nih.gov/25288534 $y Pubmed
- 910 __
- $a ABA008 $b sig $c sign $y a $z 0
- 990 __
- $a 20151005 $b ABA008
- 991 __
- $a 20151014103225 $b ABA008
- 999 __
- $a ok $b bmc $g 1092683 $s 914933
- BAS __
- $a 3
- BAS __
- $a PreBMC
- BMC __
- $a 2015 $b 42 $c 1 $d 1-7 $e 20140919 $i 1872-9614 $m Nuclear medicine and biology $n Nucl Med Biol $x MED00008576
- LZP __
- $a Pubmed-20151005
